Street Downgrades Dominate a Busy Week for Analyst Revisions

A heavy week of analyst action leaned decisively bearish, with downgrades outnumbering upgrades across technology, financials, and consumer names. Braze drew the most attention, absorbing a wave of coordinated rating cuts even as price targets rose. Tesla attracted the opposite dynamic, with several firms lifting targets after earnings.

---

Key Rating Changes

Upgrades

BLK received the week's most bullish call. TD Cowen upgraded to Buy and raised its target 16% to $1,405, against a stock price of $1,124.60.

NOC was upgraded to Outperform by Baird, with a target raised 23% to $675. The firm cited B-21 bomber and Sentinel missile production as anchors for revenue visibility.

ZM was lifted to Outperform by Oppenheimer with a $130 target, as the analyst flagged accelerating enterprise adoption of AI features.

DDOG got a significant upgrade from Bernstein, which moved to Outperform and raised its target 48% to $350, pointing to 36% revenue acceleration.

TSLA saw a cluster of post-earnings upgrades. CLSA moved from Underperform to Hold and raised its target 29% to $400. BNP Paribas lifted to Neutral with a $420 target, up from $266.

CME was upgraded to Overweight by JP Morgan with a $367 target, a sharp reversal from a prior Underweight stance.

FITB was raised to Outperform by Evercore with a $60 target.

PLD was lifted to Outperform by Raymond James, with a $163 target implying 28% upside.

AKAM received a Strong Buy from Raymond James with a $170 target, despite the stock falling 16.5% over the prior month.

IONS was upgraded to Outperform by BMO Capital, target raised to $66 from $54, implying 49% upside.

EFX was lifted to Buy by Argus Research, following an 18% earnings rally the prior week.

MTCH was raised to Outperform by Evercore ISI, target up 36% to $53.

MSM received upgrades from both Stephens (to Overweight, $135 target) and Jefferies (to Buy, $135 target) on the same day, even as the stock fell 15.4%.

HR was upgraded to Buy with a target raised to $23 from $18 on improving fundamentals.

GPN was raised to Overweight by Keybanc with a $105 target, as the firm highlighted the Worldpay deal simplification and expected capital returns.

INTC was upgraded to Neutral by JP Morgan, though the $85 target was unchanged amid a 14% weekly decline.

CLH was lifted to Buy by UBS with a $375 target, implying 15% upside.

---

Downgrades

BRZE dominated the week. At least nine analysts cut their ratings within 48 hours, including Piper Sandler, Wells Fargo, Stifel, Oppenheimer, BTIG, DA Davidson, Citigroup, Stephens, Barclays, and TD Cowen. Every firm also raised its price target, most to $47.50. The stock had surged 52% in a single session before the downgrades landed. The result was a consensus that tilted firmly to Hold despite elevated targets.

NFLX was cut by two firms in quick succession. Needham moved to Hold, citing slowing subscriber growth. Wolfe Research dropped to Peer Perform from Outperform, with the stock down 5.3% on the day.

POOL was downgraded to Neutral by Longbow Research and saw a price target cut from Stifel to $175, ahead of earnings. Short interest stood at 9.9% of float.

ACN was cut to Neutral by Baird after a 12% weekly rally, with its target nudged up to $252.

CMG was downgraded to Hold by TD Cowen, target slashed to $32 from $44.

ALLY was cut to In-Line by Evercore, target lowered to $40 from $44, citing softening auto credit conditions.

SYF was downgraded to In-Line by Evercore ISI, target cut to $78 from $80.

NCLH was dropped to Underweight by JP Morgan, target cut to $11 from $13. Short interest sits at 22% of float.

SMR was slashed to Underweight by Barclays, target cut to $5 from $11.

MBLY was cut to Underperform by RBC, target down 29% to $5.

CRUS was downgraded to Underweight by Barclays, target down 27% to $95.

AEM was cut to Hold by Freedom Broker, target reduced to $212 from $255, as the stock fell 6% on the day.

DECK was dropped to Underweight by Piper Sandler with a $75 target, a 25% downside call versus the consensus Buy.

BLDR was cut to Market Perform by William Blair, marking the sixth target reduction in six weeks.

RELX was downgraded to Neutral by Citigroup ahead of October 23 earnings, after a 17% monthly rise.

SAN was cut to Hold by Jefferies from Buy, with the stock down 9% over the prior month.

ZTS was cut to Hold by Jefferies, target down to $83 from $103.

WHR was dropped to Neutral by Longbow, with short interest at 32.2% of float.

CWST was cut to Neutral by UBS, target down 22% to $95.

---

Sector Themes

Technology: Rotation and Caution

Technology saw the sharpest divergence. Braze's mass downgrade was the clearest signal. Analysts raised targets to reflect a new price reality but withdrew conviction on further gains. CRUS, MBLY, and SMR each received aggressive cuts with Underweight or Underperform ratings. Against that, DDOG, ZM, and DOCN all received upgrades, suggesting selective optimism on AI-linked platform names rather than broad sector confidence.

Financials: Evercore Reshuffles Banks and Consumer Credit

Evercore moved across several financial names in a single day. It upgraded FITB and downgraded both ALLY and SYF. The common thread was credit quality. Auto lending and consumer credit faced pressure while regional banks with stronger fundamentals received more support. CME stood out as a bullish call from JP Morgan, which swung from Underweight to Overweight.

Consumer and Industrials: Earnings Anxiety

Ahead of a busy earnings week, analysts pulled back on consumer cyclicals. CMG, POOL, BLDR, and WHR all drew downgrades. Housing-adjacent names attracted particular scepticism. BLDR and ORI both saw targets cut as analysts flagged fragile demand and rate pressure on title insurance.

Defence: A Lone Bright Spot

NOC was the standout upgrade in industrials. Baird's 23% target increase to $675 reflected confidence in long-cycle defence programmes. With government contract visibility extending across multiple years, the sector drew one of the week's most emphatic bullish calls.